214
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

The Effect of Krocina™ on Decreasing Substance User Withdrawal Syndrome, Craving, Depression and Stress: A Double-Blind Randomized Parallel Clinical Trial

ORCID Icon, , ORCID Icon & ORCID Icon

References

  • Abbaszadeh-Mashkani, S., Hoque, S. S., Banafshe, H. R., & Ghaderi, A. (2021). The effect of crocin (the main active saffron constituent) on the cognitive functions, craving, and withdrawal syndrome in opioid patients under methadone maintenance treatment. Phytotherapy Research: PTR, 35(3), 1486–1494. https://doi.org/https://doi.org/10.1002/ptr.6913
  • Adamson, S. J., Deering, D. E., Sellman, J. D., Sheridan, J., Henderson, C., Robertson, R., Pooley, S., Campbell, S. D., & Frampton, C. M. (2012). An estimation of the prevalence of opioid dependence in New Zealand. The International Journal on Drug Policy, 23(1), 87–89.
  • Akhondzadeh, S., Tahmacebi‐Pour, N., Noorbala, A. A., Amini, H., Fallah‐Pour, H., Jamshidi, A. H., & Khani, M. (2005). Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial. Phytotherapy Research, 19(2), 148–151. https://doi.org/https://doi.org/10.1002/ptr.1647
  • Amin-Esmaeili, M., Rahimi-Movaghar, A., Sharifi, V., Hajebi, A., Radgoodarzi, R., Mojtabai, R., Hefazi, M., & Motevalian, A. (2016). Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction, 111(10), 1836–1847. https://doi.org/https://doi.org/10.1111/add.13453
  • Angarita, G. A., Emadi, N., Hodges, S., & Morgan, P. T. (2016). Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addiction Science & Clinical Practice, 11(1), 9. https://doi.org/https://doi.org/10.1186/s13722-016-0056-7
  • Asghari, A., Saed, F., & Dibajnia, P. (2008). Psychometric properties of the Depression Anxiety Stress Scales-21 (DASS-21) in a non-clinical Iranian sample. International Journal of Psychology, 2(2), 82–102.
  • Ayatollahi, H., Javan, A. O., Khajedaluee, M., Shahroodian, M., & Hosseinzadeh, H. (2014). Effect of Crocus sativus L.(saffron) on coagulation and anticoagulation systems in healthy volunteers. Phytotherapy Research: PTR, 28(4), 539–543.
  • Azadfard, M. H. M., & Leaming, J. M. (2021). Opioid Addiction. [Updated 2021 Apr 19]. In: StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK448203/.
  • Bennett, G., (1992). Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press, 1991. Pp. xvii + 348. £24.95 hardback, £11.50 paper. ISBN 0–89862–566–1. Journal of Community & Applied Social Psychology, 2(4), 299–300. https://doi.org/https://doi.org/10.1002/casp.2450020410
  • Callaly, T., Trauer, T., Munro, L., & Whelan, G. (2001). Prevalence of psychiatric disorder in a methadone maintenance population. Australian & New Zealand Journal of Psychiatry, 35(5), 601–605. https://doi.org/https://doi.org/10.1080/0004867010060507
  • Coloma-Carmona, A., Carballo, J. L., Rodríguez-Marín, J., & Pérez-Carbonell, A. (2019). Withdrawal symptoms predict prescription opioid dependence in chronic pain patients. Drug and Alcohol Dependence, 195, 27–32.
  • Curran, H. V., Kleckham, J., Bearn, J., Strang, J., & Wanigaratne, S. (2001). Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology, 154(2), 153–160. https://doi.org/https://doi.org/10.1007/s002130000628
  • Dorri, S. A., Hosseinzadeh, H., Abnous, K., Hasani, F. V., Robati, R. Y., & Razavi, B. M. (2015). Involvement of brain-derived neurotrophic factor (BDNF) on Malathion induced depressive-like behavior in subacute exposure and protective effects of crocin. Iranian Journal of Basic Medical Sciences, 18(10), 958–966.
  • Dunlap, B., & Cifu, A. S. (2016). Clinical management of opioid use disorder. JAMA, 316(3), 338–339. https://doi.org/https://doi.org/10.1001/jama.2016.9795
  • Eghtesadi, R., Safavi, S., Rasouli-Azad, M., & Ghaderi, A. (2020). The effects of saffron on psychiatric disorders: A review. International Journal of Pharmaceutical Research, 12(2), 292–302.
  • Ghaderi, A., Asbaghi, O., Reiner, Ž., Kolahdooz, F., Amirani, E., Mirzaei, H., Banafshe, H. R., Dana, P. M., & Asemi, Z. (2020). The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials. Complementary Therapies in Medicine, 48, 102250.
  • Ghaderi, A., Banafshe, H. R., Mirhosseini, N., Motmaen, M., Mehrzad, F., Bahmani, F., Aghadavod, E., Mansournia, M. A., Reiter, R. J., Karimi, M. ‐A., & Asemi, Z. (2019). The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment. Addiction Biology, 24(4), 754–764. https://doi.org/https://doi.org/10.1111/adb.12650
  • Ghaderi, A., Rasouli-Azad, M., Vahed, N., Banafshe, H. R., Soleimani, A., Omidi, A., Ghoreishi, F. S., & Asemi, Z. (2019). Clinical and metabolic responses to crocin in patients under methadone maintenance treatment: A randomized clinical trial. Phytotherapy Research, 33(10), 2714–2725. https://doi.org/https://doi.org/10.1002/ptr.6445
  • Hassani-Abharian, P., Mokri, A., Ganjgahi, H., Oghabian, M.-A., & Ekhtiari, H. (2016). Validation for Persian versions of “desire for drug questionnaire” and “obsessive compulsive drug use scale” in heroin dependents. Archives of Iranian Medicine, 19(9), 0–0.
  • Hosseini, A., Razavi, B. M., & Hosseinzadeh, H. (2018). Saffron (Crocus sativus) petal as a new pharmacological target: a review. Iranian Journal of Basic Medical Sciences, 21(11), 1091–1099.
  • Hosseinzadeh, H., & Jahanian, Z. (2010). Effect of Crocus sativus L.(saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytotherapy Research: PTR, 24(5), 726–730. https://doi.org/https://doi.org/10.1002/ptr.3011
  • Jam, I. N., Sahebkar, A. H., Eslami, S., Mokhber, N., Nosrati, M., Khademi, M., Foroutan-Tanha, M., Ghayour-Mobarhan, M., Hadizadeh, F., Ferns, G., & Abbasi, M. (2017). The effects of crocin on the symptoms of depression in subjects with metabolic syndrome. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University, 26(6), 925–930.
  • Javandoost, A., Afshari, A., Nikbakht-Jam, I., Khademi, M., Eslami, S., Nosrati, M., Foroutan-Tanha, M., Sahebkar, A., Tavalaie, S., Ghayour-Mobarhan, M., Ferns, G., Hadizadeh, F., Tabassi, A., & Mohajeri, A. (2017). Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in subjects with metabolic syndrome: A double blind randomized clinical trial. ARYA Atherosclerosis, 13(5), 245–252.
  • Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-García, A. M., & Prodanov, M. (2017). affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complementary Therapies in Medicine, 33, 58–64. https://doi.org/https://doi.org/10.1016/j.ctim.2017.06.001
  • Khalatbari-Mohseni, A., Banafshe, H. R., Mirhosseini, N., Asemi, Z., Ghaderi, A., & Omidi, A. (2019). The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial. Substance Abuse Treatment, Prevention, and Policy, 14(1), 9.
  • Malek, A., Amiri, S., & Habibi Asl, B. (2013). The therapeutic effect of adding dextromethorphan to clonidine for reducing symptoms of opioid withdrawal: A Randomized Clinical Trial. ISRN Psychiatry, 2013, 1–5. https://doi.org/https://doi.org/10.1155/2013/546030
  • Miller, W., & Rollnick, S. (1991). Principles of motivational interviewing. In Motivational interviewing: Preparing people to change addictive behavior. Guilford Press.
  • Moravej Aleali, A., Amani, R., Shahbazian, H., Namjooyan, F., Latifi, S. M., & Cheraghian, B. (2019). The effect of hydroalcoholic Saffron (Crocus sativus L.) extract on fasting plasma glucose, HbA1c, lipid profile, liver, and renal function tests in patients with type 2 diabetes mellitus: A randomized double‐blind clinical trial. Phytotherapy Research, 33(6), 1648–1657. https://doi.org/https://doi.org/10.1002/ptr.6351
  • Nemat Shahi, M., Asadi, A., Behnam Talab, E., & Nemat Shahi, M. (2017). The impact of saffron on symptoms of withdrawal syndrome in patients undergoing maintenance treatment for opioid addiction in Sabzevar parish in 2017. Advances in Medicine, 2017, 5. doi: https://doi.org/10.1155/2017/1079132.1079132.
  • Nguyen, C. D., Kim, J. W., Grunstein, R. R., Thamrin, C., & Wang, D. (2016). Respiratory variability during sleep in methadone maintenance treatment patients. Journal of Clinical Sleep Medicine, 12(4), 607–616. https://doi.org/https://doi.org/10.5664/jcsm.5702
  • Proctor, S. L., Copeland, A. L., Kopak, A. M., Hoffmann, N. G., Herschman, P. L., & Polukhina, N. (2015). Predictors of patient retention in methadone maintenance treatment. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 29(4), 906–917.
  • Rajabizadeh, G., Yazdanpanah, F., & Ramezani, M. A. (2017). The evaluation of relationship between sexual self-concept and sexual dysfunction in individuals undergoing methadone maintenance treatment. Addiction & Health, 9(2), 88–95.
  • Sahraian, A., Jelodar, S., Javid, Z., Mowla, A., & Ahmadzadeh, L. (2016). Study the effects of saffron on depression and lipid profiles: A double blind comparative study. Asian Journal of Psychiatry, 22, 174–176. https://doi.org/https://doi.org/10.1016/j.ajp.2015.10.012
  • Satre, D. D., Leibowitz, A., Sterling, S. A., Lu, Y., Travis, A., & Weisner, C. (2016). A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. Journal of Consulting and Clinical Psychology, 84(7), 571–579. https://doi.org/https://doi.org/10.1037/ccp0000096
  • Schuckit, M. A. (2016). Treatment of opioid-use disorders. The New England Journal of Medicine, 375(4), 357–368. https://doi.org/https://doi.org/10.1056/NEJMra1604339
  • Shafiee, M., Arekhi, S., Omranzadeh, A., & Sahebkar, A. (2018). Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. Journal of Affective Disorders, 227, 330–337.
  • Shoja, M., Mehri, S., Amin, B., Askari, V. R., & Hosseinzadeh, H. (2018). The prophylactic and therapeutic effects of saffron extract and crocin on ethanol withdrawal syndrome in mice. Journal of Pharmacopuncture, 21(4), 277–283.
  • Smedslund, G., Berg, R. C., Hammerstrøm, K. T., Steiro, A., Leiknes, K. A., Dahl, H. M., & Karlsen, K. (2011). Motivational interviewing for substance abuse. Cochrane Database of Systematic Reviews, (5), CD008063. https://doi.org/https://doi.org/10.1002/14651858.CD008063
  • Sotodeh Asl, N., Behnam, B., & Ghorbani, R. (2013). Effectiveness of narcotics anonymous training programs in personality characters in substance abuse patients. Koomesh, 14(3), 316–320.
  • Tabeshpour, J., Sobhani, F., Sadjadi, S. A., Hosseinzadeh, H., Mohajeri, S. A., Rajabi, O., Taherzadeh, Z., & Eslami, S. (2017). A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression. Phytomedicine, 36, 145–152. https://doi.org/https://doi.org/10.1016/j.phymed.2017.10.005
  • Talaei, A., Moghadam, M. H., Tabassi, S. A. S., & Mohajeri, S. A. (2015). Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial. Journal of Affective Disorders, 174, 51–56. https://doi.org/https://doi.org/10.1016/j.jad.2014.11.035
  • Thushara, R. M., Hemshekhar, M., Paul, M., Sundaram, M. S., Shankar, R. L., Kemparaju, K., & Girish, K. S. (2014). Crocin prevents sesamol-induced oxidative stress and apoptosis in human platelets. Journal of Thrombosis and Thrombolysis, 38(3), 321–330.
  • Vasilev, G., Milcheva, S., & Vassileva, J. (2016). Opioid use in the twenty first century: Similarities and differences across national borders. Current Treatment Options in Psychiatry, 3(3), 293–305. https://doi.org/https://doi.org/10.1007/s40501-016-0089-2
  • Wagner, C. C., & Ingersoll, K. S. (2012). Motivational interviewing in groups. Guilford Press.
  • World Drug Report 2021. (2021). United Nations Office on Drugs and Crime. https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html
  • Yarijani, Z. M., Pourmotabbed, A., Pourmotabbed, T., & Najafi, H. (2017). Crocin has anti-inflammatory and protective effects in ischemia-reperfusion induced renal injuries. Iranian Journal of Basic Medical Sciences, 20(7), 753.
  • Yin, W., Pang, L., Cao, X., McGoogan, J. M., Liu, M., Zhang, C., Li, Z., Li, J., & Rou, K. (2015). Factors associated with depression and anxiety among patients attending community‐based methadone maintenance treatment in C hina. Addiction, 110, 51–60. https://doi.org/https://doi.org/10.1111/add.12780

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.